QuidelOrtho Corp QDEL.OQ reported quarterly adjusted earnings of 12 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -7 cents. The mean expectation of nine analysts for the quarter was for earnings of one cent per share. Wall Street expected results to range from -5 cents to 7 cents per share.
Revenue fell 3.6% to $613.90 million from a year ago; analysts expected $611.20 million.
QuidelOrtho Corp's reported EPS for the quarter was a loss of $3.77.
The company reported a quarterly loss of $255.4 million.
QuidelOrtho Corp shares had fallen by 16.3% this quarter and lost 45.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 86.2% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for QuidelOrtho Corp is $50.00, about 51.8% above its last closing price of $24.11
This summary was machine generated from LSEG data August 5 at 09:53 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 0.01 | 0.12 | Beat |
Mar. 31 2025 | 0.59 | 0.74 | Beat |
Dec. 31 2024 | 0.59 | 0.63 | Beat |
Sep. 30 2024 | 0.32 | 0.85 | Beat |